DJIA 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%

Pfizer

NYSE: PFE

28.96 -0.29 (-0.99%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $28.96 -0.99%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $29.21
Previous Close $29.25
Daily Range $28.83 - $29.37
52-Week Range $21.40 - $31.15
Market Cap $205.4B
P/E Ratio 20.60
Dividend (Yield) $0.96 (3.3%)
Ex-Dividend Date
Dividend Pay Date
05/08/13
06/04/13
Volume 37,642,372
Average Daily Volume 35,616,341
Current FY EPS $2.21

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

Dow Jumps on Virtuous Cycle

Conusmer confidence numbers sent stocks soaring again as the Dow and S&P 500 finished the week at record highs.

Industrial Stocks Drive Dow’s 112-Point Day

Another week of net gains and fresh highs for blue-chip stocks as confidence rises.

Market Close Report: NASDAQ Composite index closes at 3,498.97 up 33.73 points

Cheerleaders: Look Beyond Pharma For Jobs

Any Light at the End of the Tunnel for Alzheimer's Disease?

Failed Alzheimer's disease programs litter the pharmaceutical landscape. Is there any hope for this horrible disease? Maybe so.

3 Companies That Put the "Tech" in "Biotech"

From 3-D modeling to tamper-resistant drugs to personalized genomics, these companies put the "tech" in "biotech."

Antares: Reiteration Of My Buy Recommendation

Sanofi and Regeneron's Latest Partnership

Late-stage clinical trials begin for this duo's experimental rheumatoid arthritis drug.

Angelina Jolie's Selfless Act Heightens Breast Cancer Awareness

Jolie's personal experiences brings the dangers of breast cancer into new light and also gives hope to current and future breast cancer sufferers thanks to improving therapies and diagnostic tests.

Pair of Studies Show Power of Immune System to Fight Cancer

See More PFE News...

PFE's Top Competitors

PFE $28.96 (-0.99%)
Current stock: PFE
JNJ $88.09 (0.73%)
Current stock: JNJ
MRK $45.99 (-0.82%)
Current stock: MRK
GSK $52.22 (0.21%)
Current stock: GSK